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THE PERSISTENCE of multilineage microchimerism 
after solid organ transplantation suggests long-lasting 
engraftment of donor hematopoietic progenitor cells 
(HPCs) originated from the transplanted organs. This study 
describes a method developed to identify donor HPCs in 
the recipient bone marrow and reports preliminary results 
obtained after allogeneic liver transplantation. 
METHODS 
Inbred male Lewis (LEW) and Brown Norway (BN) rats were used 
for experiments. Plastic dish nonadherent bone marrow cells 
(BMC) were prepared and cultured with 2% PWM-SCM for 6 days 
in a fibrin clot culture system to detect colony-forming units in 
culture (CFU-C). Clusters (10 to 50 cells per aggregate) and 
colonies (>50 cells per aggregate) in cultures were counted as 
CFU-C. LEW-derived CFU-C was identified by in situ immuno· 
histochemical staining of cultured cells in the fibrin clot, using a 
standard three-step avidin-biotin complex method with monoclonal 
antibody L21-6. which recognizes the class II MHC antigens of 
LEW but not BN rats. 
RESULTS 
CFU-C generated from 5 X 104 naive LEW BMC was 54 :': 
18, of which 39 :': 9% (21 :': 7) was composed of L21-6 
strong positive cells, including macrophages and dendritic-
like cells. CFU-C induced from 5 X 104 normal BN BMC 
was 43 :': 4, and none of CFU-C contained L21-6+ cells. 
When normal LEW and BN BMC were mixed at various 
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ratios (1:10, 1:100. 1:1000). L21-6+ CFU-C derived from 
the mixture were 0.2 :': 0.4, 2.3 :': 1.4. and 21.3 :': 5.7. 
respectively, and correlated to the number of LEW BMC 
contained in the culture. Finally, the engraftment of donor 
HPCs in transplant recipients was examined in a LEW to 
BN liver transplantation model. in which rejection was 
controlled with a short course of tacrolimus treatment (1 
mglkg for 14 days). L21-6+ CFU-C in BN recipient BMC 
(5 x 105 ) obtained 14 and 30 days after LEW liver 
transplantation were 1.0 :': 0.6 and 0.3 :': 0.3, respectively. 
The frequency of donor HPCs in the bone marrow of these 
recipients is estimated as 0.1 % to 0.5%, according to 
L21-6+ CFU-C counts obtained in the previous mixed 
culture experiment. 
CONCLUSION 
This study provides the strong evidence that HPCs in the 
liver graft were able to engraft into the recipient bone 
marrow after transplantation. The role of donor HPCs in 
maintaining microchimerism and donor-specific graft ac-
ceptance seen in this model is currently under investigation. 
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